Insider: Chakma Justin Chief Business Officer - ARS Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 136,380 | 0 | 136,380 |
| Value | $1,106,041.80 | $0.00 | $1,106,041.80 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 11/12/2025 | DDS | 30,000 | Direct | COM | $8.91 | $267,357.00 | 136,380 |
| 11/12/2025 | DDS | 136,380 | Direct | COM | $8.86 | $1,208,790.49 | 0 |
| 12/13/2024 | DDS | 27,272 | Direct | COM | $12.06 | $328,968.50 | 136,380 |
| 12/12/2024 | DDS | 117,333 | Direct | COM | $12.27 | $1,439,124.44 | 136,380 |
| 12/10/2024 | DDS | 50,000 | Direct | COM | $13.15 | $657,625.00 | 136,380 |
| 12/06/2024 | DDS | 50,000 | Direct | COM | $14.23 | $711,615.00 | 136,380 |
| 12/05/2024 | DDS | 49,640 | Direct | COM | $14.13 | $701,641.54 | 136,380 |
| 12/04/2024 | DDS | 45,000 | Direct | COM | $13.95 | $627,943.50 | 136,380 |
| 12/03/2024 | DDS | 45,000 | Direct | COM | $13.19 | $593,401.50 | 136,380 |
| 12/02/2024 | DDS | 45,000 | Direct | COM | $13.67 | $615,217.50 | 136,380 |
| 11/27/2024 | DDS | 25,000 | Direct | COM | $14.39 | $359,750.00 | 136,380 |
| 11/26/2024 | DDS | 42,186 | Direct | COM | $14.05 | $592,569.87 | 161,380 |
| 11/25/2024 | DDS | 32,814 | Direct | COM | $14.00 | $459,422.25 | 203,566 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research